Intra-arterial iodinated radiographic contrast material injection administration in a rat middle cerebral artery occlusion and reperfusion model: Possible effects on intracerebral hemorrhage

Stroke

Volumn 41, Issue 5, 2010, Pages 1013-1017

  Kurosawa, Yuko ^a   Lu, Aigang ^a   Khatri, Pooja ^a   Carrozzella, Janice A ^a   Clark, Joseph F ^a   Khoury, Jane ^b   Tomsick, Thomas A ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Animal model; Arterial occlusion; Contrast media; Heparin; Intracerebral hemorrhage

Indexed keywords

HEPARIN; IODINATED CONTRAST MEDIUM; PLACEBO; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPSY; BRAIN HEMORRHAGE; BRAIN INFARCTION SIZE; CONTROLLED STUDY; INCIDENCE; MALE; MANTEL HAENSZEL TEST; MIDDLE CEREBRAL ARTERY OCCLUSION; MORTALITY; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; RADIOIODINATION; RAT; REPERFUSION INJURY; SPRAGUE DAWLEY RAT; SUTURE REMOVAL; SUTURING METHOD;

ANIMALS; CEREBRAL HEMORRHAGE; CONTRAST MEDIA; DISEASE MODELS, ANIMAL; INFARCTION, MIDDLE CEREBRAL ARTERY; INJECTIONS, INTRA-ARTERIAL; IODINE RADIOISOTOPES; IOHEXOL; MALE; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; SINGLE-BLIND METHOD;

EID: 77951765783     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.110.578245     Document Type: Article

References (49)

1. Toni D, Fiorelli M, Bastianello S, Sacchetti ML, Sette G, Argentino C, Montinaro E, Bozzao L. Hemorrhagic transformation of brain infarct. Neurology. 1996;46:341-345.
2. Del Zoppo GJ, Higashida RT, Furlan AJ, Pessin MS, Rowley HA, Gent M. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke. 1998;29:4-11. (Pubitemid 28046933)
3. Kendall BE, Pullicino P. Intravascular contrast injection in ischemic lesions. Neuroradiolgy. 1980;19:241-243.
4. Hayman LA, Evans RA, Bastion FO, Hinck VC. Delayed high dose contrast CT: identifying patients at risk of massive hemorrhagic infarction. AJNR Am J Neuroradiol. 1981;136:1151-1159. (Pubitemid 12236560)
5. Dzialowski I, Puetz V, Demchuk AM. Does application of radio contrast material prior to thrombolysis impact thrombolytic effect in acute ische-mic stroke? Stroke. 2008;39:601.
6. Aviv RI, d'Esterre CD, Murphy BD, Hopyan JJ, Buck B, Mallia G, Li V, Zhang L, Symons SP, Lee TY. Hemorrhagic transformation of ischemic stroke: prediction with CT perfusion. Radiology. 2009;250:867-877.
7. Wildenhain SL, Jungreis CA, Barr J, Mathis J, Wechsler L, Horton JA. CT after intraarterial thrombolysis for acute stroke. AJNR Am J Neuro-radiol. 1994;15:487-492.
8. Urbach H, Bendszus M, Brechtelsbauer D, Solymosi L. Extravastion of contrast medium in local intraarterial fibrinolysis of the carotid territory. Nervearzt. 1998;69:490-494. (Pubitemid 28289583)
9. Khatri P, Broderick JP, Khoury JC, Carrozzella JA, Tomsick TA; IMS I and II Investigators. Microcatheter contrast injections during intraarterial thrombolysis increases intracranial hemorrhage risk. Stroke. 2008;39: 3283-3287.
10. Khatri R, Khatri P, Broderick JP, Khoury JC, Carrozzella JA, Tomsick TA; IMS I and II Investigators. Microcatheter contrast injections during intraarterial thrombolysis increase parenchymal hematoma risk: registry experience. Stroke. 2007;38:454.
11. Karibe H, Zarow GJ, Graham SH, Weinstein PR. Mild intraischemic hypothermia reduces postischemic hyperperfusion, delayed postischemic hypoperfusion, blood-brain barrier disruption, brain edema, and neuronal damage volume after temporary focal cerebral ischemia in rats. J Cereb Blood Flow Metab. 1994;14:620-627. (Pubitemid 24198405)
12. Nito C, Kamiya T, Ueda M, Arii T, Katayama Y. Mild hypothermia enhances the neuroprotective effects of FK506 and expands its therapeutic window following transient focal ischemia in rats. Brain Res. 2004;1008:179-185. (Pubitemid 38624047)
13. Zhang RL, Chopp M, Zhang ZG, Jiang Q, Ewing JR. A rat model of focal embolic cerebral ischemia. Brain Res. 1997;766:83-92. (Pubitemid 27431437)
14. Maier CM, Ahern K, Cheng ML, Lee JE, Yenari MA, Steinberg GK. Optimal depth and duration of mild hypothermia in a focal model of transient cerebral ischemia. Effects on neurologic outcome, infarct size, apoptosis, and inflammation. Stroke. 1998;29:2171-2180. (Pubitemid 28443536)
15. Tambasco N, Corea F, Luccioli R, Ciorba E, Parnetti L, Gallai V. Brain CT scan in acute ischemic stroke: early signs and functional outcome. Clin Exp Hypertens. 2002;24:687-696. (Pubitemid 35415782)
16. Lu A, Clark JF, Broderick JP, Pyne-Geithman GJ, Wagner KR, Khatri P, Tomsick T, Sharp FR. Mechanical reperfusion is associated with post-is-chemic hemorrhage in rat brain. Exp Neurol. 2009;216:407-412.
17. Lin B, Ginsberg MD. Quantitative assessment of the normal cerebral microvasculature by endothelial barrier antigen (EBA) immunohisto-chemistry: application to focal cerebral ischemia. Brain Res. 2000;865: 237-244. (Pubitemid 30256002)
18. Molina CA, Montaner J, Abilleira S, Ibarra B, Romero F, Arenillas JF, Alvarez-Sabín J. Timing of spontaneous recanalization and risk of hem-orrhagic transformation in acute cardioembolic stroke. Stroke. 2001;32: 1079-1084. (Pubitemid 32825786)
19. Corot C, Perrin JM, Belleville J, Amiel M, Eloy R. Safety and efficacy of iopromide in cerebral arteriography. Invest Radiol. 1994;29:S94-S97.
20. Spencer CM, Goa KL. Iodixanol. A review of its pharmacodynamic and pharmacokinetic properties and diagnostic use as of an X-ray contrast medium. Drugs. 1996;52:899-927. (Pubitemid 26413301)
21. Wilcox J, Wilson AJ, Evill CA, Sage MR. A comparison of blood-brain barrier disruption by intracarotid iohexol and iodixanol in the rabbit. AJNR Am J Neuroradiol. 1987;8:769-772.
22. Drake TG, Kerr HD. Status epilepticus after cranial CT with contrast media. WMJ. 1997;96:46-48. (Pubitemid 27511950)
23. Avrahami E, Weiss-Peretz J, Cohn DE. Focal epileptic activity following intravenous contrast material injection in patients with metastatic brain disease. J Neurol Neurosurg Psychiatry. 1987;50:221-223. (Pubitemid 17016565)
24. Sage MR. Blood-brain barrier: phenomenon of increasing importance to the imaging clinician. AJNR Am J Neuroradiol. 1982;138:887-898. (Pubitemid 12117586)
25. Doerfler A, Engelhorn T, von Kummer R, Weber J, Knauth M, Heiland S, Sartor K, Forsting M. Are iodinated contrast agents detrimental in acute cerebral ischemia? An experimental study in rats. Radiology. 1998; 206:211-217. (Pubitemid 28063009)
26. Brisman JL, Jilani M, McKinney JS. Contrast enhancement hyperdensity after endovascular coiling of intracranial aneurysms. AJNR Am J Neuro-radiol. 2008;29:588-593. (Pubitemid 351424080)
27. Uchiyama Y, Abe T, Hirohata M, Tanaka N, Kojima K, Nishimura H, Norbash AM, Hayabuchi N. Blood-brain barrier disruption of nonionic iodinated contrast medium following coil embolization of a ruptured intracerebral aneurysm. AJNR Am J Neuroradiol. 2004;25:1783-1786. (Pubitemid 44123706)
28. De Wispelaere JF, Trigaux JP, Van Beers B, Gilliard C. Cortical and CSF hyperdensity after iodinated contrast medium overdose: CT findings. J Comput Assist Tomogr. 1992;16:998-1003.
29. Yoon W, Seo JJ, Kim JK, Cho KH, Park JG, Kang HK. Contrast Enhancement and contrast extravasation on computed tomography after intra-arterial thrombolysis in patients with acute ischemic stroke. Stroke. 2004;35:876-881. (Pubitemid 38419795)
30. Mericle RA, Lopes DK, Fronckowiak MD, Wakhloo AK, Guterman LR, Hopkins LN. A grading scale to predict the outcomes after intraarterial thrombolysis for stroke complicated by contrast extravasation. Neuro-surgery. 2000;46:1307-1314.
31. Nakano S, Iseda T, Kawano H, Yoneyama T, Ikeda T, Wakisaka S. Parenchymal hyperdensity on computed tomography after intra-arterial reperfusion therapy for acute middle cerebral artery occlusion: incidence and clinical significance. Stroke. 2001;32:2042-2048. (Pubitemid 32868095)
32. Morcos S, Thomsen HS, Exley CM. Contrast media: interactions with other drugs and clinical tests. Eur Radiol. 2005;15:1463-1468. (Pubitemid 40983532)
33. Corot C, Perrin JM, Belleville J, Amiel M, Eloy R. Effect of iodinated contrast media on blood clotting. Invest Radiol. 1989;24:390-393. (Pubitemid 19168435)
34. Ing JJ, Smith DC, Bull BS. Differing mechanisms of clotting inhibition by ionic and nonionic contrast agents. Radiology. 1989;172:345-348. (Pubitemid 19184865)
35. Jones CI, Goodall AH. Differential effects of the iodinated contrast agents ioxaglate, iohexol and iodixanol on thrombus formation and thrombolysis. Thromb Res. 2003;112:65-71.
36. Kopko PM, Smith DC, Bull BS. Thrombin generation in nonclottable mixtures of blood and nonionic contrast agents. Radiology. 1990;174: 459-461.
37. Dawson P, Hewitt P, Mackie IJ, Machin SJ, Amin S, Bradshaw A. Contrast, coagulation, and fibrinolysis. Invest Radiol. 1986;21:248-252. (Pubitemid 16133580)
38. Grabowski EF, Rodriguez M, McDonnell SL. Platelet adhesion/aggregation in an in vitro model of coronary artery stenosis. Catheter Cardiovasc Diagn. 1993;28:65-71. (Pubitemid 23039021)
39. Markou CP, Chronos NAF, Hanson SR. Antithrombotic effects of ionic and non-ionic contrast media in nonhuman primates. Thromb Haemost. 2001;85:488-493. (Pubitemid 32233024)
40. Corot C, Stucker O, Duverger JP, Pons C, Vicaut E. Effect of iodinated contrast agents on the formation of platelet thrombi in the microarterioles of rats. Invest Radiol. 1994;29:S203-S205. (Pubitemid 24221108)
41. Zhu Y, Tomasiek R, Fay WP. Do clinically relevant circulating concentrations of radiographic contrast agents inhibit platelet-dependent arterial thrombosis? Thromb Res. 2002;105:413-418. (Pubitemid 34621259)
42. Grines CL, Mickelsen JK, Diaz C, DeMaria AN. Acute thrombosis in a canine model of arterial injury: effect of ionic versus non-ionic contrast media. J Invasive Cardiol. 1991;3(suppl):18B-23B.
43. Hwang MH, Piao ZE, Murdock DK, Giardina JJ, Pacold I, Loeb HS, Reyes CV, Scanlon PJ. Potential risk of thrombosis during coronary angiography. Radiology. 1990;174:209-213.
44. Pislaru S, Pislaru C, Szilard M, Arnout J, Van de Werf F. In vivo effects of contrast media on coronary thrombolysis. J Am Coll Cardiol. 1998; 32:1102-1110. (Pubitemid 28459606)
45. Esplugas E, Cequier A, Jara F, Mauri J, Soler T, Sala J, Sabate X. Risk of thrombosis during coronary angioplasty with low osmolarity contrast media. Am J Cardiol. 1991;68:1020-1024.
46. Tang J, Li YJ, Li Q, Mu J, Yang DY, Xie P. Endogenous tissue plas-minogen activator increases hemorrhagic transformation induced by heparin after ischemia reperfusion in rat brains. Neurol Res. 2009 Mar 23 [Epub ahead of print].
47. Guidance for Industry. Estimating safe starting doses in initial clinical trials for therapeutics in adult healthy volunteers. Available at: www.fda. gov.cder/guidance/index.htm. Accessed on December 26, 2009.
48. Treitl M, Rupprecht H, Wirth S, Korner M, Reiser M, Rieger J. Assessment of renal vasoconstriction in vivo after intra-arterial administration of the isosmotic contrast medium iodixanol compared to the low-osmotic contrast medium iopamidol. Nephrol Dial Transplant. 2009;24:1478-1485.
49. Dzialowski I, Pexman JH, Barber PA, Demchuk AM, Buchan AM, Hill MD; CASES Investigators. Asymptomatic hemorrhage after thrombolysis may not be benign. Prognosis by hemorrhage type in the Canadian Alteplase for Stroke Effectiveness Registry. Stroke. 2007;38:75-79. (Pubitemid 46035609)